查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1922993

專利卵圓孔閉合裝置市場（按裝置類型、給藥方法、材質、最終用戶和分銷管道分類）－2026-2032年全球預測

Patent Foramen Ovale Closure Device Market by Device Type, Delivery Mode, Material, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年卵圓孔閉合裝置市值為 9.1881 億美元，預計到 2026 年將成長至 9.9244 億美元，到 2032 年預計將達到 15.8575 億美元，複合年成長率為 8.10%。

關鍵市場統計數據
基準年 2025 9.1881億美元
預計年份：2026年 9.9244億美元
預測年份 2032 15.8575億美元
複合年成長率 (%) 8.10%

本文重點概述了不斷發展的介入性心臟病學生態系統，該生態系統影響房間隔封堵術的器械研發、臨床應用和採購趨勢。

專利的卵圓孔封堵器市場處於介入性心臟病學、器材工程和醫療系統經濟學的交匯點，將臨床醫生、製造商和支付方匯聚在一個複雜的創新生態系統中。本執行摘要概述了房間隔封堵解決方案的演變現狀，重點介紹了關鍵促進因素，包括手術偏好的變化、材料科學的進步以及對長期安全性和患者報告結果的日益關注。它還探討了設計選擇、交付流程和終端用戶環境將如何影響現有和新興供應商的採用趨勢和競爭策略。

臨床實務趨勢、材料創新和醫療保健領域動態的融合如何重塑醫療器材設計重點、應用路徑和商業策略

近年來，臨床實踐、器材工程和醫療服務模式的融合推動了卵圓孔未閉封堵通暢性領域的變革，並重新定義了該領域。微創技術的成熟使得經皮介入治療備受關注，操作者的熟練程度和導管檢查室的高效運作有助於縮短住院時間並加快患者康復。同時，設計創新也著重於更小巧的輸送系統和更方便的取出方式，以滿足臨床醫師對術中操作柔軟性和病人安全性的需求。

美國近期加徵關稅對營運和採購產生了連鎖反應，推動了供應鏈本地化、合約審查以及對醫療保健總成本的重新關注。

2025年，美國關稅政策對醫療設備供應鏈、商業策略和採購計畫產生了顯著影響，促使製造商和醫療系統重新評估採購和定價策略。關稅調整凸顯了在地化生產、供應商多元化和庫存最佳化的重要性，因為企業都在尋求降低採購成本波動並保持競爭力。這些營運調整往往會引發一些長期決策，例如生產地點的選擇、哪些零件需要自主生產，以及如何建構分銷協議以保障利潤率和供應穩定性。

針對特定細分市場的產品設計、臨床應用和商業性推廣的影響因素，可以從醫療設備類型、給藥方式、材料選擇、臨床環境和分銷管道等方面來衡量。

細分市場層面的趨勢揭示了不同的機會和風險特徵，這些特徵應指導產品開發和市場推廣計劃。這適用於器械類型、給藥方式、材料、終端用戶環境和分銷策略。不同器械類型的考慮因素顯示了不同的部署路徑。室間隔封堵器強調易於部署和長期組織整合，而縫合系統則優先考慮非侵入性封堵以及在特定解剖情況下的潛在優勢。同時，給藥方式的差異仍具有重要影響。經皮途徑通常與導管檢查室的工作流程和操作者培訓計劃相符，而外科手術對於混合手術和需要直視及同期手術的高度複雜病例仍然至關重要。

美洲、歐洲、中東、非洲和亞太地區的區域差異會影響產品的採用路徑、監管協調和商業化策略。

區域趨勢對美洲、歐洲、中東和非洲以及亞太地區的監管路徑、臨床應用和商業策略產生了顯著影響，每個地區都呈現出不同的機會環境和營運考量。在美洲，先進的介入性心臟病學網路和集中式卓越中心正在推動器械改進的快速普及，這些改進顯著降低了手術複雜性並提高了患者周轉率。醫保報銷環境和私立醫院的採購流程也對哪些創新最終能夠進入常規臨床實踐起著至關重要的作用。

透過整合服務模式實現競爭差異化，該模式支持臨床證據、設備人體工學、實施支援和與臨床醫生建立長期夥伴關係。

老牌製造商與新參與企業之間的競爭主要集中在實證醫學證據的累積、與臨床醫生的合作以及供應鏈的卓越性。主要企業正大力投資穩健的臨床項目，以檢驗產品的安全性和長期療效，同時改善器械的人體工學設計和輸送系統，以減少術中併發症。與大型臨床中心建立策略聯盟以及參與註冊研究是加速累積真實世界證據並有助於與支付方進行報銷談判的常用策略。

為設備製造商和醫療保健系統制定明確且優先的行動方案，以加強房間隔封堵術市場的臨床可靠性、供應鏈韌性和商業性靈活性。

行業領導者應優先採取一系列行動，以在不斷變化的臨床和商業性環境中保持永續的競爭優勢。首先，投資於有針對性的臨床證據項目，檢驗長期安全性、功能性結果以及與其他封鎖策略的比較性能，以消除支付方的疑慮並支持指南的發布。其次，優先改進器械，例如提高輸送性、縮短手術時間和提高回收率，以應對臨床醫生面臨的挑戰，並在以導管為中心的醫療環境中加速器械的普及應用。

一個透明的混合方法研究框架，結合臨床醫生訪談、監管審查和比較分析，以得出檢驗的研究結果和背景限制因素。

本執行摘要的研究採用了混合方法，整合了定性訪談、文獻綜述和監管比較分析，從而對器械、臨床和商業性趨勢進行了多角度的觀點。一級資訊來源包括與介入性心臟病專家、醫院採購人員、臨床試驗研究人員和分銷合作夥伴的結構化訪談，旨在了解實際操作中的偏好、培訓需求和採購考慮。二級資訊來源包括同儕審查的臨床文獻、監管指導文件以及已發布的植入式醫療設備安全和報告標準。

關鍵策略要務的整合表明，臨床證據、強大的業務運作和有針對性的商業化將決定產品的長期應用和市場定位。

總之，卵圓孔未閉封堵術這一專利器材領域正處於一個十字路口，臨床創新、材料科學、商業策略和監管管理正在交匯融合，共同塑造其未來發展軌跡。關鍵促進因素包括手術操作簡單、可證實的長期治療效果、供應鏈的適應性以及能夠反映總治療成本的商業模式。那些能夠將產品開發與臨床醫生需求相結合、投資於有意義的真實世界數據並建立穩健的生產和分銷基礎設施的相關人員，將最有利於獲得持續的價值。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依器械類型分類的專利卵圓孔閉合裝置市場

  • 心房中隔封堵器
  • 縫合線輸送系統

9. 依給藥途徑分類的卵圓孔閉合專利裝置市場

  • 經皮
  • 外科

第10章 依材質分類的專利卵圓孔閉合裝置市場

  • 鎳鈦諾
  • 聚合物

第11章 依最終用戶分類的專利卵圓孔閉合裝置市場

  • 門診手術中心
  • 心臟診所
  • 醫院
    • 私立醫院
    • 公立醫院

第12章 專利卵圓孔閉合裝置市場（依分銷管道分類）

  • 離線
  • 線上

第13章 各地區專利卵圓孔閉合裝置市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 依組別分類的專利卵圓孔閉合裝置市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各國專利卵圓孔閉合裝置市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國專利卵圓孔閉合裝置市場

第17章 中國專利卵圓孔閉合裝置市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Artech Medical
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardia, Inc.
  • Cardiovascular Systems, Inc.
  • Coherex Medical, Inc.
  • Cook Medical LLC
  • Medtronic plc
  • Neovasc Inc.
  • NMT Medical, Inc.
  • Occlutech International AG
  • Sahajanand Medical Technologies Pvt. Ltd.
  • Shanghai Mallow Medical Instrument Co., Ltd.
  • Starway Medical Technology Inc.
  • Surmodics, Inc.
  • Vascular Innovations Co., Ltd.
  • WL Gore & Associates, Inc.
Product Code: MRR-867BED9A9EAC

The Patent Foramen Ovale Closure Device Market was valued at USD 918.81 million in 2025 and is projected to grow to USD 992.44 million in 2026, with a CAGR of 8.10%, reaching USD 1,585.75 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 918.81 million
Estimated Year [2026] USD 992.44 million
Forecast Year [2032] USD 1,585.75 million
CAGR (%) 8.10%

A focused overview of the evolving interventional cardiology ecosystem shaping device development, clinical adoption, and procurement dynamics in septal closure therapies

The patent foramen ovale closure device landscape sits at the intersection of interventional cardiology, device engineering, and health system economics, bringing together clinicians, manufacturers, and payers in a complex innovation ecosystem. This executive summary introduces the contemporary context in which septal closure solutions are evolving, highlighting key drivers such as procedural preference shifts, material science advancements, and increasing attention to longitudinal safety and patient-reported outcomes. It frames the conversation around how design choices, delivery workflows, and end-user settings influence adoption and the competitive calculus for incumbent and emerging suppliers.

Clinical decision-making increasingly balances minimally invasive approaches against institutional capabilities and clinician experience. Concurrently, regulatory scrutiny and post-market surveillance demand robust evidence of durability and biocompatibility. As a result, development roadmaps are emphasizing both iterative improvements to device profiles and novel delivery concepts that reduce procedural complexity. Beyond technical considerations, stakeholders must engage with payer frameworks and reimbursement nuances that shape hospital procurement and ambulatory center uptake. The following sections expand on transformative shifts, tariff impacts, segmentation insights, regional dynamics, competitor positioning, actionable recommendations, and the methodological basis for our findings to provide a coherent narrative for strategic planning and operational execution.

How converging clinical practice trends, material innovations, and site-of-care dynamics are reshaping device design priorities, adoption pathways, and commercial strategies

Recent years have produced transformative shifts that are redefining the patent foramen ovale closure landscape, driven by converging forces in clinical practice, device engineering, and healthcare delivery models. Minimally invasive techniques have matured, prompting greater interest in percutaneous approaches where operator familiarity and catheterization laboratory workflows support reduced hospital stays and accelerated recovery. At the same time, design innovation has emphasized reduced profile delivery systems and enhanced retrievability to address clinician preferences for intra-procedural flexibility and improved patient safety.

Material science progress, particularly with superelastic alloys and polymer coatings, has improved device conformability and tissue integration, which in turn shapes regulatory expectations and post-market evidence generation. Parallel to technical evolution, value-based care initiatives are influencing site-of-care decisions, with ambulatory surgical centers and outpatient-focused cardiac clinics increasingly evaluated for procedural suitability. Supply chain resilience and channel diversification have become priorities for manufacturers, leading to expanded distributor relationships and digital sales pathways. Collectively, these shifts have created an environment in which iterative clinical evidence, user-centered design, and adaptive commercialization strategies determine competitive differentiation and long-term market relevance.

The cascading operational and procurement consequences of recent U.S. tariff measures prompting supply chain localization, contracting revisions, and renewed focus on total cost of care

In 2025, tariff policies introduced by the United States have had measurable implications across medical device supply chains, commercial strategies, and procurement planning, prompting manufacturers and health systems to reassess sourcing and pricing approaches. Tariff adjustments have amplified the importance of localized manufacturing, supplier diversification, and inventory optimization as firms seek to mitigate input cost volatility and preserve competitive positioning. These operational shifts often translate into longer-term decisions about where to locate production, which components to insource, and how to structure distribution agreements to protect margins and supply reliability.

For health systems and purchasing teams, tariff-related cost pressures have reinforced scrutiny of total procedure costs and prompted renewed negotiations with vendors around bundled pricing, consignment models, and performance-based payment structures. At the same time, companies are accelerating efforts to demonstrate value beyond unit pricing by emphasizing procedure efficiency, reduced complication rates, and shorter length-of-stay metrics. Regulatory and customs complexities introduced by tariff regimes have also highlighted the need for transparent documentation, robust supplier qualification processes, and scenario planning to ensure continuity of care. Taken together, these dynamics are catalysing a strategic rebalancing of global sourcing, commercial contracting, and risk management practices across the sector.

Segment-specific implications for product design, clinical deployment, and commercial engagement framed across device types, delivery approaches, material choices, care settings, and distribution channels

Segment-level dynamics reveal differentiated opportunity and risk profiles that should shape product development and go-to-market plans across device types, delivery modes, materials, end-user settings, and distribution strategies. Considerations by device type illustrate divergent pathways: septal occluders emphasize ease of deployment and chronic tissue integration, while suture mediated systems prioritize atraumatic closure and potential advantages in specific anatomical scenarios. In parallel, delivery mode distinctions remain influential; percutaneous approaches are typically aligned with catheterization lab workflows and operator training programs, whereas surgical delivery retains relevance in hybrid or high-complexity cases where direct visualization or concomitant procedures are required.

Material selection continues to be a primary design lever, with nitinol offerings valued for superelasticity and predictable conformability and polymer variants explored for reduced imaging artifact and tailored bioresorption profiles. End-user segmentation highlights how ambulatory surgical centers demand streamlined device profiles and rapid turnover amenability, cardiac clinics focus on procedural throughput and ambulatory follow-up capabilities, and hospitals-both private and public-assess devices within broader procurement frameworks that consider training, inventory, and post-market surveillance responsibilities. Finally, distribution strategy nuances matter: direct sales relationships enable deep clinical engagement and training, distributors provide reach and logistics optimization, and online channels support access to consumables and information; together these channels shape market access models and customer experience across the care continuum.

How regional variations across the Americas, Europe Middle East and Africa, and Asia-Pacific influence adoption pathways, regulatory alignment, and commercialization strategies

Regional dynamics significantly influence regulatory pathways, clinical adoption, and commercial strategies across the Americas, Europe Middle East and Africa, and Asia-Pacific, each presenting distinct opportunity landscapes and operational considerations. In the Americas, sophisticated interventional cardiology networks and concentrated centers of excellence support rapid uptake of device iterations that demonstrably reduce procedure complexity and improve patient throughput. Reimbursement environments and private hospital procurement processes also play a central role in shaping which innovations clear pathways into routine practice.

Across Europe, the Middle East and Africa, regulatory harmonization efforts, varying payer structures, and heterogenous hospital infrastructure lead manufacturers to pursue adaptive market entry strategies that prioritize evidence generation aligned to national health technology assessment requirements and strategic partnerships with local distributors and clinical champions. The Asia-Pacific region often combines high-volume procedural demand with diverse regulatory regimes, presenting both scale potential and the need for localized value propositions, supply chain agility, and culturally adapted clinical training programs. In all regions, a clear understanding of site-of-care preferences, referral patterns, and clinician network influence is critical to crafting differentiated commercialization plans and ensuring sustainable uptake over time.

Competitive differentiation driven by clinical evidence, device ergonomics, and integrated service models that support adoption and long-term clinician partnerships

Competitive positioning among established manufacturers and newer entrants centers on evidence generation, clinician engagement, and supply chain excellence. Leading companies are investing in robust clinical programs to validate safety and long-term outcomes while refining device ergonomics and delivery systems to reduce intra-procedural complexity. Strategic partnerships with high-volume clinical centers and participation in registry initiatives are common tactics to accelerate real-world evidence accumulation and to support reimbursement discussions with payers.

Smaller innovators frequently pursue niche strategies by addressing specific anatomical challenges or by introducing materials and coatings that target improved tissue integration or reduced imaging artifact. These companies may leverage distributor networks or digital engagement platforms to amplify reach while managing capital intensity. Across the competitive field, differentiation increasingly depends on the ability to provide training, simulation, and post-market support, as purchasers weigh not only device performance but also the total service package that governs procedural success and patient outcomes. As a result, successful market players combine clinical credibility, operational reliability, and transparent commercial terms to build durable relationships with healthcare providers.

Clear and prioritized actions for device makers and health systems to strengthen clinical credibility, supply chain resilience, and commercial agility in septal closure markets

Industry leaders should pursue a set of prioritized actions to maintain relevance and capture sustainable advantage amid evolving clinical and commercial dynamics. First, invest in targeted clinical evidence programs that address long-term safety, functional outcomes, and comparative performance versus alternative closure strategies to reduce payer friction and support guideline inclusion. Second, prioritize iterative device improvements that enhance deliverability, reduce procedural time, and improve retrievability, thereby addressing clinician pain points and accelerating adoption in catheter-centric settings.

Third, develop flexible manufacturing and sourcing strategies to mitigate tariff and supply chain risks, including options for localized production or qualified alternative suppliers to preserve continuity and margin discipline. Fourth, cultivate multi-channel commercial models that balance the depth of direct clinical engagement with the breadth of distributor and digital channels, enabling scalable training, remote support, and inventory management. Fifth, align with health system priorities by articulating total cost of care advantages and offering outcome-linked contracting models where appropriate. By executing these actions with disciplined project management and clinician co-creation, organizations can convert current disruptions into durable competitive capabilities.

A transparent mixed-methods research framework combining clinician interviews, regulatory review, and comparative analysis to produce validated insights and contextual limitations

The research underpinning this executive summary was constructed using a mixed-methods approach that integrated primary qualitative interviews, secondary literature review, and comparative regulatory analysis to create a multidimensional perspective on device, clinical, and commercial dynamics. Primary inputs included structured discussions with interventional cardiologists, hospital procurement leaders, clinical trial investigators, and distribution partners to surface real-world procedural preferences, training needs, and procurement considerations. Secondary sources encompassed peer-reviewed clinical literature, regulatory guidance documents, and published standards governing implantable device safety and reporting.

Analytical procedures employed cross-validation techniques to reconcile divergent perspectives and to ensure internal consistency among clinical claims, engineering trade-offs, and commercial behaviours. Geographic comparisons relied on country-level regulatory frameworks and health system typologies to contextualize regional differences. Throughout the process, attention was paid to data provenance, transparency of assumptions, and the limitations inherent to publicly available information and interview sampling. This methodological rigor supports the credibility of the insights while acknowledging areas where further targeted data collection-such as longitudinal registries or payer-specific economic analyses-would strengthen decision-making.

Synthesis of critical strategic imperatives showing how clinical evidence, resilient operations, and targeted commercialization will determine long-term adoption and positioning

In conclusion, the patent foramen ovale closure device field stands at a juncture where clinical innovation, material science, commercial strategy, and regulatory stewardship converge to shape future trajectories. Key drivers include procedural simplification, demonstrable long-term outcomes, supply chain adaptability, and commercial models that reflect total cost of care. Stakeholders that align product development with clinician needs, invest in meaningful real-world evidence, and design resilient manufacturing and distribution footprints will be best positioned to capture durable value.

Looking forward, the interplay between regional regulatory environments, site-of-care trends, and evolving payer expectations will continue to influence which device attributes become decisive. Early and sustained engagement with clinical champions, thoughtful segmentation-based commercialization, and proactive risk mitigation against tariff and logistics disruption are prudent. Ultimately, the capacity to convert technical advantages into measurable clinical and economic outcomes will determine market leadership and sustained adoption across diverse healthcare settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Patent Foramen Ovale Closure Device Market, by Device Type

  • 8.1. Septal Occluder
  • 8.2. Suture Mediated System

9. Patent Foramen Ovale Closure Device Market, by Delivery Mode

  • 9.1. Percutaneous
  • 9.2. Surgical

10. Patent Foramen Ovale Closure Device Market, by Material

  • 10.1. Nitinol
  • 10.2. Polymer

11. Patent Foramen Ovale Closure Device Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Cardiac Clinics
  • 11.3. Hospitals
    • 11.3.1. Private Hospitals
    • 11.3.2. Public Hospitals

12. Patent Foramen Ovale Closure Device Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. Patent Foramen Ovale Closure Device Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Patent Foramen Ovale Closure Device Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Patent Foramen Ovale Closure Device Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Patent Foramen Ovale Closure Device Market

17. China Patent Foramen Ovale Closure Device Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Artech Medical
  • 18.7. Biotronik SE & Co. KG
  • 18.8. Boston Scientific Corporation
  • 18.9. Cardia, Inc.
  • 18.10. Cardiovascular Systems, Inc.
  • 18.11. Coherex Medical, Inc.
  • 18.12. Cook Medical LLC
  • 18.13. Medtronic plc
  • 18.14. Neovasc Inc.
  • 18.15. NMT Medical, Inc.
  • 18.16. Occlutech International AG
  • 18.17. Sahajanand Medical Technologies Pvt. Ltd.
  • 18.18. Shanghai Mallow Medical Instrument Co., Ltd.
  • 18.19. Starway Medical Technology Inc.
  • 18.20. Surmodics, Inc.
  • 18.21. Vascular Innovations Co., Ltd.
  • 18.22. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY SEPTAL OCCLUDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY SEPTAL OCCLUDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY SEPTAL OCCLUDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY SUTURE MEDIATED SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY SUTURE MEDIATED SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY SUTURE MEDIATED SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY PERCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY PERCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY PERCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY SURGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY SURGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY SURGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY NITINOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY NITINOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY CARDIAC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY CARDIAC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY CARDIAC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. AMERICAS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. GCC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GCC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. GCC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 115. GCC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 116. GCC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. GCC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 118. GCC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 133. G7 PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. G7 PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. G7 PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 136. G7 PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 137. G7 PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. G7 PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 139. G7 PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. NATO PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. NATO PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. NATO PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 143. NATO PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 144. NATO PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. NATO PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 146. NATO PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 151. UNITED STATES PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 152. UNITED STATES PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. UNITED STATES PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. CHINA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 156. CHINA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. CHINA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 158. CHINA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 159. CHINA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. CHINA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)